Benjamin F. Edwards & Company, Inc. Dynavax Technologies Corp Transaction History

Benjamin F. Edwards & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$13.09 - $14.98 $4,175 - $4,778	-319 Reduced 49.92%	320 $4,000
Q3 2023 Nov 13, 2023	BUY	$12.64 - $14.99 $8,076 - $9,578	639 New	639 $9,000
Q2 2018 Jul 19, 2018	SELL	$15.15 - $20.75 $1,515 - $2,075	-100 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$14.65 - $19.9 $1,465 - $1,989	100 New	100 $2,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.